Michael Gelband’s BiomX PHGE Stock Holding History

Michael Gelband’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-90	Closed	-$120K	–	1966
2020 Q1	$120K	Sell	90 -36	-29%	-$62.8K	0.01%	863
2019 Q4	$232K	Buy	+126	New	+$217K	﹤0.01%	1276

Other funds holding PHGE

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Michael Gelband's PHGE Position: Q2 2020 in Review

Michael Gelband sold out of BiomX (PHGE) in Q2 2020, closing a stake of 90 shares — an estimated $120K sold.

Michael Gelband first reported a position in PHGE in Q4 2019 and held it in 2 quarters. The position peaked at $232K in Q4 2019. 12 funds tracked by Wall St. Rank hold PHGE as of Q2 2020.

Michael Gelband reported no remaining BiomX position as of Q2 2020 after selling out during the quarter.
Michael Gelband sold 90 BiomX shares in Q2 2020, an estimated $120K.
Michael Gelband first reported a position in BiomX in Q4 2019 and held it in 2 quarters.
Michael Gelband's BiomX position peaked at $232K in Q4 2019.
12 funds tracked by Wall St. Rank held BiomX as of Q2 2020.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.